Regulatory Organization Effectiveness & Capability Building

The Work

Regulatory organizations are routinely asked to support more products, more geographies, more innovation, and more scrutiny — without proportional growth in headcount, tools, or operating clarity. The result is predictable: senior leaders absorbed in escalations, mid-level reviewers stretched across categories that don't share workflows, and a function that's measured on compliance but expected to deliver strategy.

Most regulatory dysfunction does not come from a lack of technical talent. It comes from unclear decision rights, weak business partnering with R&D and commercial, an operating model that hasn't been redesigned in a decade, and governance debt accumulated through reorganizations, acquisitions, and reactive hiring. Diagnostics that stop at a benchmark miss the point. The question is not how a regulatory function compares; it is what is keeping this specific organization from doing the work it actually needs to do.

RGM brings direct operating experience to this work. The founder designed and led the operating model for a ~170-person global regulatory organization at Sanofi Consumer Healthcare, with responsibility across categories, geographies, and product portfolios — including the practical reality of restructuring, integrating acquired teams, and clarifying decision rights between regulatory, R&D, quality, and commercial. That experience is what separates a benchmark report from a transformation roadmap a leadership team can actually run with.

A roadmap is more useful than a benchmark because it tells the team what to do on Monday. It sequences the work, identifies dependencies, names owners, and ties each initiative to a business outcome the rest of the leadership team already cares about.